The Victorian Virtual Emergency Department, or VVED, began life in October 2020 as a pandemic-era initiative at Northern Health in Melbourne, designed to relieve pressure on a crowded physical emergency department by treating lower-acuity patients at home. Demand grew so quickly that by February 2022 it had expanded into a 24/7, state-wide service staffed around the clock by emergency nurses, emergency physicians, nurse practitioners and general practitioners. Today it ranks among the largest virtual emergency departments in the world, with more than 800,000 consultations logged by March 2026. During the study period, spanning July 2022 to June 2023, it handled 100,422 presentations, roughly 5.3 percent of all public emergency department presentations recorded across Victoria in the same window.

What sets the new analysis apart is its methodological scale. Previous evaluations of virtual emergency care have largely been confined to pilot programmes, single-site audits, or patient satisfaction surveys, leaving open the crucial question of what actually happens to patients after the video call ends. To answer that, the research team used the Centre for Victorian Data Linkage to connect VVED records to the Victorian Emergency Minimum Dataset, which captures every public emergency department presentation in the state, and the Victorian Admitted Episodes Dataset, covering all hospital admissions. The result was a linked cohort of 100,422 consultations from 80,161 individual patients, tracked across eight distinct referral pathways, from self-referrals through paramedic, ambulance, aged care, and urgent care centre referrals.

The headline numbers are striking. Three-quarters of all patients, 76 percent, were managed entirely at home following their virtual consultation. Only 15 percent were directed to a physical emergency department, and a mere 0.3 percent required direct hospital admission. Among those sent home, just 8.2 percent turned up at a physical emergency department within 48 hours, rising to 11.4 percent within seven days, with hospital admissions of 4.1 and 6.6 percent respectively. Those figures compare favourably with international benchmarks: re-presentation rates after discharge from physical emergency departments range from about 5 percent in Australia to more than 30 percent overseas, and British and Canadian virtual urgent care models have reported unplanned attendance rates of 10.5 and 13.7 percent respectively.

The researchers also found evidence that the service is changing the shape of demand across the entire state system. Recent analysis of more than 11 million Victorian emergency presentations between 2018 and 2024 documented a decline in low-acuity triage category 4 and 5 attendances, with avoidance strategies such as the VVED cited as a likely contributor. Victoria was also the only Australian state to record a fall in ambulance incidents in 2024–25, a 5.4 percent drop attributed in part to active management of lower-acuity cases, with the VVED now one of Ambulance Victoria’s largest alternative care pathways. Crucially, the low unplanned re-presentation rate suggests the avoidance reflects appropriate clinical selection rather than dangerous under-triage.

When the team dug into which patients were most likely to bounce back to a hospital, diagnosis emerged as the decisive factor. In multivariable mixed-effects logistic regression covering 65,860 presentations managed in the community, the only variable independently associated with unplanned emergency presentation within 48 hours was the primary ICD-10 diagnostic category. Conditions amenable to assessment by history and visual inspection performed especially well: skin and subcutaneous tissue disorders showed 73 percent lower odds of re-presentation compared with non-specific symptoms, ear conditions such as suspected middle ear infection showed 70 percent lower odds, and respiratory illnesses and minor injuries also fared significantly better. Patients coded under vague symptom categories, the authors note, may simply have had illnesses that had not yet declared themselves, with their higher return rates reflecting appropriate safety-netting advice rather than failures of virtual care.

The picture grows more nuanced for clinically complex patients arriving through healthcare professional referral pathways, including paramedics, residential aged care facilities, and urgent care centres. These referrals involve older, frailer patients with multiple chronic conditions, and when their condition deteriorated, hospital admission was often the appropriate outcome. Among patients sent home from these pathways, admission rates reached 6.3 percent for ambulance referrals and 6.9 percent for aged care referrals within 48 hours. Yet even here, three-quarters were successfully managed at home without any emergency attendance or admission, suggesting the virtual service can safely handle a substantial share of clinically complex cases that would otherwise trigger a hospital transfer.

One surprising finding may reshape how virtual services communicate with patients. Linked data revealed that a third of patients advised to attend a physical emergency department never showed up within 48 hours, a non-compliance rate remarkably consistent with Australian telephone triage services, where 34 percent of callers told to attend immediately also failed to comply within 24 hours. The authors speculate that perceptions of illness severity, trust in medical advice, transport barriers, symptom improvement, or preferences for community-based alternatives may all influence what patients do after the screen goes dark. They caution that presentations to private emergency departments, not captured in the linked datasets, may also account for part of the gap, and they flag this group as a priority for safety research.

The study’s limitations are acknowledged candidly. It captures a single year during the service’s implementation phase, excludes private emergency department use, and relies on administrative coding that may contain inaccuracies. Residual record linkage error, potentially non-random across population subgroups, remains possible. The cohort was also predominantly Australian-born and English-speaking, underrepresenting culturally diverse communities relative to Victoria’s broader population, where roughly 30 percent of residents were born overseas. The authors note that future evaluations should embed Aboriginal and Torres Strait Islander data governance, and that longer-term outcomes including mortality, patient decision-making, equity of access, and rigorous health economic analysis all remain to be established at scale.

Even so, the implications for health systems worldwide grappling with unsustainable emergency demand are hard to ignore. At a population scale exceeding 100,000 consultations, an avoidance rate above 80 percent represents a meaningful reduction in physical emergency attendances, achieved with unplanned re-presentation rates equal to or better than those following discharge from physical emergency departments and rival remote care models. The authors conclude that virtual emergency departments can serve as a scalable complement to traditional emergency services, provided policymakers design referral pathways carefully for higher-risk groups such as frail older adults in residential aged care. As emergency systems confront ageing populations, rising chronic disease, and chronic overcrowding, Victoria’s experiment suggests the emergency department of the future may increasingly begin not in a corridor, but on a screen.

Subject of Research: Population-level outcomes of a state-wide virtual emergency department in Victoria, Australia, using linked emergency and hospital administrative data

Article Title: Outcomes of a state-wide virtual emergency department in Victoria, Australia: a linked data analysis of emergency department utilisation and hospital use

Article References: Sher, L. M., Jessup, R. L., Boyd, J. H., Hutton, J., Suleiman, M., Lawrence, J., Miller, S., Nehme, Z., Bevan, D., & Semciw, A. I. (2026). Outcomes of a state-wide virtual emergency department in Victoria, Australia: a linked data analysis of emergency department utilisation and hospital use. The Lancet Regional Health – Western Pacific, 74, Article 101985. https://doi.org/10.1016/j.lanwpc.2026.101985

Image Credits: AI Generated

DOI: 10.1016/j.lanwpc.2026.101985

Keywords: virtual emergency department, telehealth, emergency medicine, data linkage, hospital utilisation, Victoria, digital health, health services research, ED avoidance, patient outcomes, Outcomes, state-wide

The significance of the question is difficult to overstate. Diagnostic labels in psychiatry are not merely administrative conveniences; they shape treatment decisions, prognosis conversations, eligibility for services, disability determinations, and the direction of a patient’s entire clinical trajectory. When a young person presents with hallucinations, delusions, disorganized thinking, or negative symptoms for the first time, clinicians face acute pressure to classify the presentation quickly. The Diagnostic and Statistical Manual of Mental Disorders, in its fifth edition, formalized the other specified schizophrenia spectrum and other psychotic disorder category precisely to accommodate presentations that are clinically significant but fall short of complete diagnostic thresholds, whether because symptom duration, symptom count, or functional decline criteria are not fully met. In practice, this category has often been treated clinically as a probable precursor to schizophrenia, a kind of pre-diagnosis that carries an implicit expectation of progression.

That expectation, the new research suggests, may be systematically wrong. By following individuals who received a first-episode diagnosis within the other specified category and tracking both their diagnostic course and their functional and symptomatic outcomes over time, the investigators assembled a longitudinal picture of what actually happens to this population. If the category were merely an early stage of schizophrenia, one would expect the majority of cases to convert to a full schizophrenia diagnosis as symptoms consolidate and duration criteria are eventually satisfied. If the category instead captured a heterogeneous mix of transient, attenuated, or genuinely atypical psychotic experiences, one would expect substantial migration in multiple directions, with many patients improving, some shifting to other spectrum diagnoses, and a minority remaining stably within the unspecified label. The study’s findings, summarized in its title as evidence for a distinct clinical entity, point toward the latter pattern, with a profile of outcomes that does not simply recapitulate the natural history of first-episode schizophrenia.

From a methodological standpoint, the study addresses one of the most persistent weaknesses in psychosis research: the tendency to exclude or lump together patients who do not fit clean diagnostic categories. Large longitudinal cohorts of first-episode psychosis frequently stratify participants by diagnosis, comparing schizophrenia, schizoaffective disorder, affective psychosis with psychotic features, and brief psychotic disorder. Patients carrying other specified diagnoses are often either folded into a residual group or dropped from analyses altogether, a practice that both inflates the apparent homogeneity of named categories and renders the most diagnostically uncertain patients invisible to science. By placing this group at the center of inquiry rather than the margin, the study recovers a population that is common in real-world clinical settings, particularly in early intervention services where careful, provisional first diagnoses are the norm.

The clinical implications of diagnostic stability data are immediate and practical. When clinicians can tell a patient and family that a given first-episode diagnosis carries a known probability of remaining stable, of resolving, or of evolving into another condition, the conversation changes from one of vague reassurance to one of quantified expectation. For the other specified category, the traditional assumption of inevitable progression toward schizophrenia has arguably generated unwarranted pessimism, potentially influencing clinicians and families to interpret ambiguous developments through the darkest available lens. A more accurate empirical picture, in which many individuals with this diagnosis do not progress to schizophrenia and may show outcomes better than typically reported for first-episode schizophrenia itself, could recalibrate prognostic communication, reduce stigma associated with the initial diagnosis, and encourage appropriately intensive but not fatalistic monitoring.

The study also speaks to a deeper theoretical tension in psychiatric nosology. Since the reliability-focused reforms of DSM-III in 1980, diagnostic categories in psychiatry have been treated as if they carve nature at its joints, yet decades of research on symptom dimensions, genetic correlations, and transdiagnostic mechanisms have repeatedly suggested that psychosis exists on continua rather than in discrete boxes. The other specified category occupies an awkward position in this debate. Critics have argued that such residual categories are nosological dustbins that undermine the validity of the system by concealing heterogeneity. Proponents counter that they honestly reflect the limits of current diagnostic science while preserving clinical flexibility. Evidence that a residual category shows internal coherence, in the form of reasonably stable diagnoses and a characteristic outcome profile, would challenge the dustbin interpretation and lend support to the possibility that some presentations currently labeled as other specified represent a genuinely identifiable syndrome that current criteria simply lack the vocabulary to name.

The distinction matters enormously for early intervention research and service design. Early intervention in psychosis programs, which have proliferated internationally and demonstrated meaningful benefits for functional recovery, typically enroll patients within a defined window after the first psychotic episode and tailor treatment intensity to expected risk. If a substantial fraction of patients carrying provisional unspecified diagnoses actually have a milder or more remitting condition, blanket application of protocols designed for schizophrenia may represent both an inefficient allocation of intensive resources and an iatrogenic risk, exposing individuals to antipsychotic treatment durations and prognostic messaging calibrated to a more severe illness than the one they have. Conversely, if a meaningful subset of these patients does deteriorate, identifying reliable early predictors of that trajectory becomes a priority. Longitudinal outcome data of the kind reported in this study provide the empirical foundation on which such stratified approaches must be built, because risk prediction is only as good as the outcome distributions it is trained to anticipate.

The findings also carry weight for the ongoing revision debates surrounding psychiatric classification. The research community preparing future editions of the DSM and the International Classification of Diseases has grappled with proposals ranging from dimensional severity ratings to wholesale reorganization of the psychosis section. Any proposal to promote, split, merge, or retire diagnostic categories ultimately depends on longitudinal evidence about stability, outcomes, and treatment response. A demonstration that the other specified schizophrenia spectrum category functions as a distinct clinical entity, rather than as an early or attenuated form of schizophrenia, would argue for either a named and criterion-defined diagnosis in future classifications or, at minimum, explicit guidance distinguishing it from the prodromal and precursor states with which it is often conflated. Classification follows evidence, and evidence of this kind is precisely what has been missing.

As with any single study, the new findings invite replication across independent cohorts, diverse health systems, and longer follow-up horizons, and they raise the familiar interpretive challenges of observational psychiatric research, including the influence of treatment on observed trajectories and the possibility that referral patterns shape who receives the unspecified label in the first place. Yet the core contribution stands on its own terms. A diagnosis long treated as an administrative compromise, a reluctant concession to diagnostic uncertainty, has been subjected to the same longitudinal scrutiny applied to schizophrenia itself and has emerged with a recognizable clinical identity. For the many patients who carry this label during the most disorienting period of their lives, and for the clinicians and families navigating that period alongside them, the message is a quietly radical one: an unspecified diagnosis is not a disguised certainty of schizophrenia, and the natural history of this condition deserves to be understood, studied, and treated on its own evidence.

Subject of Research: Clinical outcomes and diagnostic stability in first-episode other specified schizophrenia spectrum and other psychotic disorder

Article Title: Clinical outcomes and diagnostic stability in first-episode other specified schizophrenia spectrum and other psychotic disorder: evidence for a distinct clinical entity

Article References: Setiani, A., Li, L., Odkhuu, S., Kim, W.-S., Nazir, S., Starzer, M. S. K., Weibell, M., Chen, E. Y. H., Liu, C.-C., Mizuno, M., & Chung, Y.-C. (2026). Clinical outcomes and diagnostic stability in first-episode other specified schizophrenia spectrum and other psychotic disorder: evidence for a distinct clinical entity. Schizophrenia. https://doi.org/10.1038/s41537-026-00804-4

Image Credits: AI Generated

DOI: 10.1038/s41537-026-00804-4

Keywords: schizophrenia spectrum, first-episode psychosis, diagnostic stability, DSM-5, psychiatric nosology, early intervention, clinical outcomes, psychotic disorders, prognosis, longitudinal study, Clinical, outcomes

Triple-negative breast cancer, defined by the absence of estrogen receptor and progesterone receptor expression and the lack of HER2 amplification, accounts for roughly 10 to 15 percent of all breast cancers but carries a disproportionate share of early recurrences and deaths. Because the tumor lacks the molecular targets that make other breast cancer subtypes vulnerable to endocrine therapy or HER2-directed drugs, cytotoxic chemotherapy has remained the backbone of treatment. Historically, anthracycline-and-taxane regimens have been the standard of care, producing pathologic complete response rates of roughly 37 to 41 percent. When patients achieve a pathologic complete response, meaning no residual invasive cancer is found in the breast or lymph nodes at the time of surgery, their five-year event-free survival approaches 90 percent, compared with 57 percent for those who do not. That makes the response a powerful surrogate for cure and a critical endpoint for evaluating treatment strategies.

The trouble with anthracyclines lies in what they leave behind. Pooled data from randomized controlled trials show that patients treated with anthracycline-containing regimens face more than a five-fold higher risk of clinical cardiotoxicity, as well as sharply elevated risks of acute myeloid leukemia and myelodysplastic syndrome. Long-term follow-up studies in breast cancer survivors have documented heart failure, arrhythmias, and secondary blood cancers years or decades after the original diagnosis. For young women facing the prospect of decades of survival after successful breast cancer treatment, these late effects are not trivial side effects; they are life-altering or life-shortening complications in their own right. Reducing or eliminating anthracycline exposure without sacrificing cancer control has therefore become one of the most consequential questions in early breast cancer management.

At the same time, the treatment landscape has been transformed by two major developments. The first is the incorporation of carboplatin, a platinum chemotherapy agent, into neoadjuvant regimens. Trials such as GeparSixto, CALGB 40603, and BrighTNess demonstrated that adding carboplatin increases pathologic complete response rates in triple-negative disease, although often at the cost of substantially more hematologic toxicity, treatment delays, and dose reductions. The second development is immunotherapy. The landmark KEYNOTE-522 trial established perioperative pembrolizumab, an antibody that blocks the PD-1 immune checkpoint, combined with neoadjuvant chemotherapy as the new standard of care for stage II and III disease, improving both pathologic complete response and overall survival. Yet real-world experience with that regimen has revealed higher-than-anticipated immune-related adverse events, frequent discontinuation, and dose reductions, raising concerns about how much drug burden patients can realistically tolerate.

Against this shifting backdrop, a research team led by investigators at the University of Iowa and the University of Wisconsin, working with the Greater Plains Collaborative, a PCORnet clinical research network spanning ten medical centers across nine states, asked a deceptively simple question: in actual clinical practice, does adding anthracyclines to carboplatin plus taxane chemotherapy improve outcomes? They compared two regimens among women with stage I to III triple-negative breast cancer diagnosed between 2012 and 2024. The first, abbreviated CbT, consisted of carboplatin plus a taxane. The second, AC-CbT, added doxorubicin plus cyclophosphamide, the classic anthracycline combination. The primary outcome was pathologic complete response as recorded in hospital cancer registries by treating physicians, supplemented where necessary by comparisons of pre-treatment clinical staging and post-surgical pathologic staging.

The results were striking in their clarity. Among the 878 women analyzed, 41.2 percent received the anthracycline-free CbT regimen and 58.8 percent received AC-CbT. Half of the entire cohort achieved a pathologic complete response. On the surface, the anthracycline group appeared to fare slightly better, with response rates of 51.9 percent versus 47.2 percent for CbT, but this difference was not statistically significant. More importantly, after multivariable adjustment using inverse probability weighting, accounting for age, stage, grade, race, body mass index, comorbidity, treatment site, and pembrolizumab use, the addition of anthracyclines conferred no meaningful advantage, with an adjusted odds ratio of 1.05 and a confidence interval spanning 0.69 to 1.59. Sensitivity analyses that reclassified ambiguous response data or excluded those cases entirely produced the same conclusion.

What did predict response? Pembrolizumab use nearly doubled the odds of pathologic complete response, with an adjusted odds ratio of 1.97. Higher-grade tumors were more likely to respond, paradoxically, with grade 3 disease carrying nearly twice the odds of grade 1 or 2 tumors, a pattern consistent with the principle that the most biologically aggressive cancers are often the most sensitive to chemotherapy. Lower stage predicted higher response, as expected, and women diagnosed between ages 40 and 49 were roughly twice as likely to respond as those diagnosed at 60 or older, a finding the investigators probed extensively with post hoc and machine-learning analyses without uncovering an obvious explanation. Notably, an interaction analysis showed no evidence that anthracyclines mattered more or less depending on whether pembrolizumab was given, suggesting the anthracycline question remains unresolved in both the immunotherapy era and outside it.

The study also documents a dramatic practice transformation. Among all 2,413 triple-negative breast cancer patients in the underlying dataset, use of any carboplatin-containing regimen rose from 7.1 percent in 2012 to 72.8 percent in 2024. Pembrolizumab uptake was swift following the 2021 publication of KEYNOTE-522 results, and by the end of the study period, 46 percent of the analytic cohort had received it, concentrated overwhelmingly in the anthracycline-containing group. Interestingly, the data reveal how oncologists tailor care in the real world: older patients and those with comorbidities were more likely to forgo anthracyclines, while those with stage III, more aggressive disease were more likely to receive all four cytotoxic drug classes. Nearly a third of patients received combinations that had never appeared in clinical guidelines, reflecting deliberate individualized risk-benefit balancing rather than rigid protocol adherence.

Perhaps most provocative is the finding that carboplatin has penetrated into stage I disease, a population excluded from KEYNOTE-522 and still recommended anthracycline-taxane therapy by National Comprehensive Cancer Network guidelines. Among all stage I patients in the dataset, 19.4 percent received carboplatin, rising from 3.4 percent in 2012 to 41.7 percent in 2024. Within the analytic cohort, stage I patients showed similar response rates with or without anthracyclines. This off-guideline adoption finds precedent in the adjuvant PATTERN trial, in which carboplatin plus paclitaxel matched anthracycline-based therapy in five-year overall survival, with three-quarters of enrolled patients having node-negative disease.

The investigators are careful to acknowledge limitations. As an observational study relying on electronic health records and registry data, it cannot exclude unmeasured confounding, and variables such as performance status, BRCA mutation status, treatment toxicity, adherence, and relative dose intensity were unavailable. Lower delivered doses in the four-drug regimen could theoretically explain the lack of anthracycline benefit, although the authors argue that real-world tolerability is itself a legitimate measure of a regimen’s worth. The cohort also lacked racial diversity, and a notable fraction of responses were classified as “not otherwise specified,” though sensitivity analyses confirmed the robustness of the central finding.

Even with those caveats, the study represents, to the authors’ knowledge, the largest real-world analysis of triple-negative breast cancer spanning the immunotherapy era, and it provides the strongest real-world evidence yet that anthracyclines may not earn their place alongside carboplatin-based chemoimmunotherapy. Ongoing randomized trials, most notably the SCARLET trial evaluating anthracycline-free chemoimmunotherapy against the full KEYNOTE-522 regimen, will determine whether anthracycline omission can be definitively declared noninferior. Until then, this research shifts the burden of proof: the question is no longer whether patients can safely be spared anthracyclines, but whether the drugs still have anything left to offer.

Subject of Research: Anthracycline-containing versus anthracycline-free carboplatin-based regimens in early-stage triple-negative breast cancer: real-world outcomes

Article Title: Anthracycline-containing versus anthracycline-free carboplatin-based regimens in early-stage triple-negative breast cancer: real-world outcomes

Article References: Kroll, M. R., Schroeder, M. C., Neuner, J. M., Viyyuri, B. R., Ravindra, A., McDougall, D., Chapman, C. G., Fleege, N. M. G., Chrischilles, E. A., Song, X., & Phadke, S. (2026). Anthracycline-containing versus anthracycline-free carboplatin-based regimens in early-stage triple-negative breast cancer: real-world outcomes. Breast Cancer Research and Treatment, 219(2), Article 7. https://doi.org/10.1007/s10549-026-08071-8

Image Credits: AI Generated

DOI: 10.1007/s10549-026-08071-8

Keywords: Anthracycline-containing, versus, anthracycline-free, carboplatin-based, regimens, early-stage, triple-negative, breast, cancer, real-world, outcomes, scientific research

These figures deserve careful reflection because they come from a group of people whose primary reason for visiting the hospital was the management of a chronic physical illness rather than a mental health concern. In many low- and middle-income countries, chronic disease clinics are structured around biomedical monitoring: blood pressure readings, blood glucose measurements, prescription refills, and brief consultations. Psychological suffering in such settings can remain invisible unless clinicians actively ask about it. The pattern observed in this study suggests that distress is not an occasional complication of chronic illness but a common companion to it. When more than two thirds of a sample reports extremely severe anxiety, the finding points to a systemic gap in care rather than an isolated clinical problem.

The study also examined how participants coped with illness-related challenges, drawing on the Africultural Coping Systems Inventory, a measure designed to capture coping strategies rooted in African cultural contexts. This choice of instrument is significant. Much of the coping literature has been developed in Western settings and tends to emphasize individual-oriented strategies such as problem-focused planning or cognitive reframing. The Africultural Coping Systems Inventory instead recognizes approaches that are commonly observed in African communities, including collective coping, in which family members, friends, and community networks share the burden of a problem, and cognitive-emotional debriefing, in which individuals work through their feelings by talking them out with others. Measuring these strategies acknowledges that coping is a culturally embedded behavior, not a universal script.

Gender differences emerged in both distress and coping. Female participants reported significantly higher depression, anxiety, and stress scores than male participants, and the effect sizes fell in the moderate-to-large range, indicating differences that are not merely statistical artifacts but meaningful disparities in lived experience. Male participants, by contrast, reported significantly greater use of collective coping and cognitive-emotional debriefing, although the effect sizes here were small. This asymmetry in magnitude is noteworthy. The gender gap in psychological distress was substantial, while the gender gap in coping strategies, though statistically reliable, was more modest. In other words, women in this sample were carrying considerably more emotional weight, and the coping differences detected did not appear large enough on their own to explain that burden fully.

Several lines of reasoning, supported by broader scientific understanding of chronic disease and mental health, help contextualize these findings. Hypertension and diabetes are both conditions that require sustained self-management, and the demands of that management interact with social and economic circumstances. Women in many households assume caregiving responsibilities not only for themselves but for children, partners, and older relatives, which can compress the time and energy available for managing their own health. Dietary recommendations, medication schedules, and clinic visits may be harder to follow when a person is also responsible for feeding a family or working in informal employment without sick leave. Economic vulnerability can also amplify the stress of a condition that requires regular medication, since interruptions in supply or affordability are common in resource-constrained health systems.

The finding of extremely severe anxiety in a majority of participants also invites attention to the biological and psychological interplay between chronic metabolic or cardiovascular disease and emotional states. Anxiety and stress activate physiological pathways that can affect blood pressure and glycemic control, creating a potential feedback loop in which poor mental health worsens the physical condition, which in turn deepens distress. Depression is similarly consequential: it is associated with reduced medication adherence, poorer dietary self-care, and less engagement with follow-up care, all of which can compromise long-term outcomes in hypertension and diabetes. Recognizing this bidirectional relationship strengthens the argument, made by the study’s authors, that routine mental health screening should be embedded within chronic disease clinics rather than treated as a separate service that patients must seek out on their own.

Screening, however, is only a first step. Identification of distress must be linked to accessible psychosocial support, and the study’s findings about coping strategies offer guidance on what such support should look like. Because men in the sample leaned on collective coping and cognitive-emotional debriefing, interventions that mobilize family and community structures may resonate more effectively than purely individual approaches. Support groups organized through existing chronic disease clinics, peer-led discussion sessions, and involvement of household members in counseling could build on strategies that patients already find natural. Culturally relevant care of this kind respects the social fabric through which many Ghanaians navigate illness, rather than importing models that assume an isolated, self-reliant patient.

The higher distress reported by women suggests that gender-sensitive care must go beyond identical treatment for all. It requires attention to the specific pressures women face, which may include economic dependence, caregiving overload, and, in some contexts, limited autonomy in health decisions. Health workers could be trained to ask about these circumstances during routine visits, and referral pathways to counseling or social services could be established within the hospitals where patients already receive care. Task-shifting approaches, in which nurses or trained lay counselors deliver basic psychological interventions, have been explored in various low-resource settings and may offer a practical route to expanding mental health support without requiring large numbers of specialist psychiatrists or psychologists.

The study’s methodology also merits consideration when interpreting its results. As a cross-sectional investigation, it captured a single moment in time for each participant, which means it can document associations between gender, coping, and distress but cannot establish causal direction. It remains possible, for example, that higher distress shapes how people cope rather than the reverse, or that both are influenced by unmeasured factors such as disease duration, severity, income, or social support quality. The reliance on self-report measures introduces the possibility of response bias, and the recruitment of patients from two public hospitals in one region means the findings may not generalize to people managing chronic conditions in private care, in rural communities distant from hospitals, or in other countries. DASS-21 is a screening tool that categorizes symptom severity but is not itself a diagnostic instrument, so the reported percentages reflect symptom burden rather than clinical diagnoses of depressive or anxiety disorders.

Even with these caveats, the scale of the distress documented is difficult to dismiss. The analytic approach, using descriptive statistics and independent t-tests conducted in Jamovi statistical software, was straightforward and transparent, and the moderation of claims about coping differences through small effect sizes reflects a careful reading of the data. The open access publication of the work, carried in Discover Social Science and Health, makes the evidence available to practitioners, policymakers, and researchers in Ghana and beyond, which is particularly valuable for a topic that has received limited attention in resource-constrained settings.

For clinicians, the most immediate implication is the value of asking. A brief, validated screening question about mood or worry during a routine hypertension or diabetes visit costs little and can uncover suffering that patients may not volunteer. For health system planners, the findings argue for integrating mental health services into chronic disease care, a model sometimes described as collaborative or integrated care, so that psychological support becomes a routine component of managing conditions that patients will live with for decades. For communities and families, the findings highlight the role that collective coping already plays and the potential to strengthen it deliberately.

For researchers, the study opens several avenues. Longitudinal designs could clarify how coping strategies and distress influence each other over the course of chronic illness, and how clinical outcomes such as blood pressure control or glycemic stability relate to mental health over time. Qualitative work could illuminate what severe anxiety feels like for a patient managing diabetes in a context of medication shortages, or how women experience the competing demands of illness and family responsibility. Intervention studies could test whether culturally grounded psychosocial support reduces distress and improves self-management.

Ultimately, the study underscores that chronic medical conditions and mental health are inseparable dimensions of the same human experience. The 457 patients who shared their experiences in two hospitals in Ghana’s Central Region reveal a population carrying a heavy and unevenly distributed psychological burden. Women bear more of the distress; men, on average, draw somewhat more on collective and debriefing strategies. Neither pattern can be addressed by biomedical care alone. A health response that treats the blood pressure reading and the glucose value as the whole story will miss the anxiety, depression, and stress documented here. A response that includes routine screening, gender-sensitive support, and culturally relevant psychosocial care would align chronic disease treatment with the full reality of patients’ lives.

The authors’ conclusion, that mental health screening and gender-sensitive, culturally relevant psychosocial support should be considered within chronic disease clinics, is a practical and evidence-based recommendation. Its implementation would require training, resources, and coordination, but the alternative is a system in which the majority of patients with chronic illness experience extreme anxiety without anyone asking about it. This study provides the local evidence needed to begin changing that.

Subject of Research: Gender differences in coping strategies and mental health outcomes among people living with chronic medical conditions

Article Title: Gender differences in coping strategies and mental health outcomes among people living with chronic medical conditions

Article References: Ninnoni, J. P. K., Commey, I. T., Harmah, E. B., Amoadu, M., & Opoku-Danso, R. (2026). Gender differences in coping strategies and mental health outcomes among people living with chronic medical conditions. Discover Social Science and Health. https://doi.org/10.1007/s44155-026-00479-3

Image Credits: AI Generated

DOI: 10.1007/s44155-026-00479-3

Keywords: Gender, differences, coping, strategies, mental, health, outcomes, people, living, chronic, medical, conditions

The observation that synchronous remote and face-to-face theoretical instruction produced comparable knowledge acquisition is consistent with a substantial body of literature from medical and health professions education. The so-called no significant difference phenomenon, first documented decades ago in distance education research, has repeatedly shown that when content, pacing, instructor quality, and learner engagement are held constant, the delivery medium itself rarely determines learning outcomes for declarative knowledge. What this study adds is a veterinary-specific and surgically contextualized confirmation of that pattern, using a standardized one-hour lesson on bovine tenotomy of the deep digital flexor tendon delivered to novice learners with no prior surgical experience. The randomization, the use of identical slides, images, and instructional guidance across groups, and the controlled classroom environment all strengthen the internal validity of this comparison and address common confounders in modality research, such as instructor variability and content drift between formats.

Equally important is what the study reveals about the limits of theoretical preparation alone. In both groups, initial practical performance was strikingly limited, with few students able to complete the procedure correctly on a first attempt. This result should not be read as a failure of the students or of the instruction, but rather as evidence about the nature of surgical skill itself. Procedural competence depends on the integration of conceptual understanding with visuospatial perception, instrument handling, tissue interaction, and real-time corrective feedback, capacities that cannot be fully encoded through verbal and visual description alone. Cognitive load theory offers a useful framework here: novices confronted with a complex novel motor task experience intrinsic load that overwhelms working memory, and textual or pictorial prelearning, while necessary, is insufficient to scaffold execution without live modeling and guided practice. The significant improvement observed on the second attempt, following an in-person instructor-led demonstration, illustrates the well-established pedagogical principle that observation of expert modeling followed by deliberate, repeated practice with feedback is a far more potent driver of early skill acquisition than preprocedural instruction by itself.

The design of the study deserves attention because it isolates a specific and practically relevant question. Rather than comparing entire curricula or long-term outcomes, the investigators examined a single instructional sequence: theoretical lesson, first attempt, demonstration, second attempt. This granularity matters for curriculum planners because regulatory frameworks operate at the level of workload distribution, while learning happens at the level of sequenced instructional events. The evidence suggests that remote delivery can occupy a legitimate place in that sequence as the vehicle for conceptual preparation, provided that it is followed by supervised in-person experiences that include demonstration, repetition, and feedback. The comparable improvement between groups during the second attempt further suggests that the benefits of in-person demonstration were not modulated by how the preceding theoretical content had been delivered, reinforcing the idea that remote and in-person elements can be complementary rather than competing.

It is worth situating these results within the broader literature on simulation and skills training in surgical education across species and professions. Research in human surgical training has repeatedly demonstrated that theoretical knowledge and technical skill are only weakly correlated, and that structured skills laboratories, model-based simulation, and progressive mastery learning outperform knowledge-focused preparation for the development of manual competence. Veterinary education faces additional challenges, including the heterogeneity of patient size and anatomy, the ethical and economic constraints on animal use for teaching, and the limited availability of cadaveric and clinical material. In this context, the tenotomy model used in the study is instructive: it is a fundamental procedure that integrates core elements of surgical technique, including aseptic preparation, tissue handling, hemostasis, and closure, while being feasible to teach in a controlled laboratory setting. Findings from such standardized procedures can plausibly generalize to other basic surgical skills, though extrapolation to more complex procedures, live animal surgery, or clinical decision-making under uncertainty should be made cautiously.

The choice of a bovine model also carries practical significance for the Brazilian context, where large animal practice represents a substantial share of professional activity and where curricular reforms affect a large and diverse student population. Third-semester students represent the earliest stage at which surgical exposure typically occurs, making them an appropriate population for studying initial performance rather than refined competence. The restricted sample size, justified by a power analysis based on a large anticipated effect size, is adequate for detecting major differences between groups but limits the precision of estimates and the ability to detect smaller effects or interactions. Readers should therefore interpret the absence of significant differences as an absence of evidence for a modality effect under these conditions, not as definitive proof of equivalence. Replication with larger cohorts, multiple institutions, additional procedures, and longer follow-up would strengthen the evidentiary basis for curricular policy.

The Brazilian regulatory developments that motivated this study reflect a global trend toward flexibility in professional education, driven in part by expanded digital infrastructure, pandemic-era experience with emergency remote teaching, and economic pressures on higher education. However, the study’s conclusions offer a measured counterweight to purely administrative interpretations of that flexibility. If semipresential formats allow theoretical coursework to move online, the implication is not that practical training can be proportionally reduced, but rather that in-person time should be concentrated and protected for the activities that demonstrably require it: demonstration, supervised practice, feedback, and progressive refinement. This reframing could actually improve curricula by making explicit the distinction between knowledge transmission, which digital tools handle well, and skill formation, which depends on physical supervision and repeated deliberate practice. The danger identified in the study’s conclusions, that curricular expansion of non-presential components might erode the quantity and quality of hands-on training, is a real one, and the empirical finding that novices perform poorly without live demonstration provides concrete support for maintaining robust practical components.

The study also highlights the importance of instructional design quality in remote delivery. The theoretical lesson was not a passive lecture but a structured session with standardized visual and verbal guidance, delivered synchronously so that students could interact in real time. Synchronous formats preserve many of the pedagogical affordances of the classroom, including immediate clarification of doubts and instructor awareness of student comprehension, which may explain why remote delivery performed comparably to in-person teaching for knowledge outcomes. This distinction between synchronous and asynchronous digital learning is often blurred in public debate, yet it is likely to be critical in professional programs. Asynchronous content may serve well for review, preparation, and reinforcement, but the real-time guidance examined here more closely mirrors traditional teaching and may be the more appropriate substitute within a blended sequence.

From a methodological standpoint, the use of a standardized assessment before and after demonstration provides a within-subject dimension that strengthens the study beyond a simple between-group comparison. The significant within-group improvement from first to second attempt demonstrates the sensitivity of the practical scoring instrument to genuine performance change, which supports the validity of the between-group null result. Future work could extend this design by adding further practice trials, delayed retention testing, and transfer tasks, which would reveal whether the demonstrated gains persist and generalize. Incorporating validated measures of technical skill, such as structured checklists and global rating scales completed by blinded assessors, as well as objective motion analysis where feasible, would further enrich the evidence base.

Ultimately, the contribution of this study lies less in resolving the debate about remote education than in sharpening its terms. It suggests that the productive question for veterinary curricula is not whether digital delivery is superior or inferior to face-to-face teaching in the abstract, but which learning objectives, at which stages of training, and within which instructional sequences, each modality should carry. For theoretical foundations, the evidence supports the legitimacy of synchronous remote instruction under structured conditions. For initial technical execution among novices, the evidence affirms the indispensability of live modeling and supervised practice. As Brazilian veterinary programs adapt to the new regulatory landscape, studies of this kind, conducted with randomized designs, standardized procedures, and transparent reporting, provide the empirical scaffolding needed to design blended curricula that expand access and flexibility without compromising the practical competence that the profession, and the animals under its care, fundamentally require.

Subject of Research: Initial surgical performance in veterinary training: theoretical instruction modality and practical outcomes before and after instructor-led demonstration

Article Title: Initial surgical performance in veterinary training: theoretical instruction modality and practical outcomes before and after instructor-led demonstration

Article References: Paredes, S. L., Callegarette, N. C., Mendes, R. P., Rocha, P. S., Vallejo, K. A. G., & Correa, R. R. (2026). Initial surgical performance in veterinary training: theoretical instruction modality and practical outcomes before and after instructor-led demonstration. Global Surgical Education – Journal of the Association for Surgical Education, 5(1), Article 175. https://doi.org/10.1007/s44186-026-00582-8

Image Credits: AI Generated

DOI: 10.1007/s44186-026-00582-8

Keywords: Initial, surgical, performance, veterinary, training, theoretical, instruction, modality, practical, outcomes, instructor-led, demonstration